Dapiglutide for Obesity - A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

被引：0
|
作者：
Nielsen, Casper Kjaesgaard
Palsson, Thorir
Jensen, Benjamin
Johansen, Nicklas
Pedersen, Miriam
Forman, Julie
Lund, Asger
Knop, Filip Krag
机构：
来源：
OBESITY | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Poster-320
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [31] A PROOF-OF-CONCEPT DOUBLE-BLIND RANDOMISED PLACEBO-CONTROLLED TRIAL OF PROBIOTICS IN SYSTEMIC SCLEROSIS ASSOCIATED GASTROINTESTINAL DISEASE
    Low, A. H. L.
    Teng, G. G.
    Pettersson, S.
    De Sessions, P. F.
    Fan, Q.
    Law, A.
    Santosa, A.
    Lim, A.
    Thumboo, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 153 - 153
  • [32] Effect of Rubus Occidentalis Extract on Metabolic Parameters in Subjects with Prediabetes: A Proof-of-concept, Randomized, Double-blind, Placebo-controlled Clinical Trial
    An, Jee Hyun
    Kim, Dong-Lim
    Lee, Tae-Bum
    Kim, Kyeong Jin
    Kim, Sun Hwa
    Kim, Nam Hoon
    Kim, Hee Young
    Choi, Dong Seop
    Kim, Sin Gon
    PHYTOTHERAPY RESEARCH, 2016, 30 (10) : 1634 - 1640
  • [33] The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial
    Abdallah, Mahmoud Samy
    Eldeen, Ahmed Hossam
    Tantawy, Sally Said
    Mostafa, Tarek Mohamed
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 906
  • [34] MULTICENTER DOUBLE-BLIND, PROOF-OF-CONCEPT, RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RIOCIGUAT IN SYSTEMIC SCLEROSIS-ASSOCIATED DIGITAL ULCERS (RESCUE)
    Khanna, Dinesh
    Spino, Cathie
    Nagaraja, Vivek
    Domsic, Robin
    Lafyatis, Robert
    Steen, Viginia
    Gordon, Jessica
    Frech, Tracy
    Tsou, Pei-Suen
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1216 - 1217
  • [35] Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
    Marvin R. McCreary
    Patrick M. Schnell
    Dale A. Rhoda
    Scientific Reports, 12
  • [36] Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
    McCreary, Marvin R.
    Schnell, Patrick M.
    Rhoda, Dale A.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [37] Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial
    Alavi, Afsaneh
    Prens, Errol P.
    Kimball, Alexa B.
    Frew, John W.
    Krueger, James G.
    Mukhopadhyay, Sutirtha
    Gao, Heli
    Ranganathan, Usha
    Ivanoff, Nathalie B.
    Hernandez Daly, Ana C.
    Zouboulis, Christos C.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (04) : 508 - 518
  • [38] The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept study
    Brunner, Lisa-Marie
    Riebel, Marco
    Wein, Simon
    Koller, Michael
    Zeman, Florian
    Huppertz, Gunnar
    Emmer, Tanja
    Eberhardt, Yvonne
    Schwarzbach, Jens
    Rupprecht, Rainer
    Nothdurfter, Caroline
    TRIALS, 2024, 25 (01)
  • [39] A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SIRUKUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    van Vollenhoven, R.
    Aranow, C.
    Rovin, B.
    Wagner, C.
    Zhou, B.
    Gordon, R.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 78 - 78
  • [40] Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS): a study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept study
    Ederoth, Per
    Grins, Edgars
    Dardashti, Alain
    Bronden, Bjorn
    Metzsch, Carsten
    Erdling, Andre
    Nozohoor, Shahab
    Mokhtari, Arash
    Hansson, Magnus J.
    Elmer, Eskil
    Algotsson, Lars
    Jovinge, Stefan
    Bjursten, Henrik
    BMJ OPEN, 2016, 6 (12):
12345